MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):278-279. doi: 10.15585/mmwr.mm7008e1.
On January 9, 2021, the Minnesota Department of Health (MDH) announced the identification of the SARS-CoV-2 variant of concern (VOC) B.1.1.7, also referred to as 20I/501Y.V1 and VOC 202012/01, in specimens from five persons; on January 25, MDH announced the identification of this variant in specimens from three additional persons. The B.1.1.7 variant, which is reported to be more transmissible than certain other SARS-CoV-2 lineages* (1), was first reported in the United Kingdom in December 2020 (1). As of February 14, 2021, a total of 1,173 COVID-19 cases of the B.1.1.7 variant had been identified in 39 U.S. states and the District of Columbia (2). Modeling data suggest that B.1.1.7 could become the predominant variant in the United States in March 2021 (3).
2021 年 1 月 9 日,明尼苏达州公共卫生部(MDH)宣布在五名患者的样本中发现了令人关注的 SARS-CoV-2 变异株(VOC)B.1.1.7,也称为 20I/501Y.V1 和 VOC 202012/01;1 月 25 日,MDH 宣布在另外三名患者的样本中发现了这种变异株。B.1.1.7 变异株据称比某些其他 SARS-CoV-2 谱系更具传染性*(1),于 2020 年 12 月在英国首次报告(1)。截至 2021 年 2 月 14 日,在美国 39 个州和哥伦比亚特区(2)共发现了 1173 例 B.1.1.7 变异株的 COVID-19 病例。建模数据表明,B.1.1.7 可能在 2021 年 3 月成为美国的主要变异株(3)。